Howard Liang - 28 Jun 2021 Form 4 Insider Report for BeiGene, Ltd. (ONC)

Role: CFO & Chief Strategy Officer
Signature: /s/ Qing Nian, as Attorney-in-Fact
Issuer symbol: ONC
Transactions as of: 28 Jun 2021
Net transactions value: -$162,790
Form type: 4
Filing time: 30 Jun 2021, 16:45:49 UTC
Previous filing: 21 Jun 2021
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	BGNE	American Depositary Shares	Sale	$162,790	-446	-100%	$365.00	0	28 Jun 2021	Direct	F1, F2
holding	BGNE	Ordinary Shares						1,553,149	28 Jun 2021	Direct

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Howard Liang is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may continue.

Explanation of Responses:

Id	Content
F1	Each American Depositary Share represents 13 Ordinary Shares.
F2	The sale was effected pursuant to a mandatory tax withholding provision in the Reporting Person's restricted share unit award agreement in connection with the vesting of a restricted share unit award previously granted to the Reporting Person. 1/4th of the securities will vest on each anniversary of June 26, 2018, subject to continued service. Unvested securities are subject to accelerated vesting upon a sale event.

Content

Each American Depositary Share represents 13 Ordinary Shares.

The sale was effected pursuant to a mandatory tax withholding provision in the Reporting Person's restricted share unit award agreement in connection with the vesting of a restricted share unit award previously granted to the Reporting Person. 1/4th of the securities will vest on each anniversary of June 26, 2018, subject to continued service. Unvested securities are subject to accelerated vesting upon a sale event.